FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

26855811000001108: Ranitidine 75mg tablets (Ennogen Healthcare Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Sep 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
83407201000001115 Ranitidine 75mg tablets (Ennogen Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
83407301000001112 Ranitidine 75mg tablets (Ennogen Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ranitidine 75mg tablets (Ennogen Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ranitidine 75mg tablets (Ennogen Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ranitidine 75mg tablets (Ennogen Healthcare Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Ranitidine 75mg tablets (Ennogen Healthcare Ltd) Is a Product containing precisely ranitidine (as ranitidine hydrochloride) 75 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Ranitidine 75mg tablets (Ennogen Healthcare Ltd) Has active ingredient Ranitidine hydrochloride false Inferred relationship Existential restriction modifier
Ranitidine 75mg tablets (Ennogen Healthcare Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Ranitidine 75mg tablets (Ennogen Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ranitidine 75mg tablets (Ennogen Healthcare Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Ranitidine 75mg tablets (Ennogen Healthcare Ltd) Has specific active ingredient Ranitidine hydrochloride true Inferred relationship Existential restriction modifier
Ranitidine 75mg tablets (Ennogen Healthcare Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ranitidine 75mg tablets (Ennogen Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ranitidine true Inferred relationship Existential restriction modifier
Ranitidine 75mg tablets (Ennogen Healthcare Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ranitidine 75mg tablets (Ennogen Healthcare Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Ranitidine 75mg tablets (Ennogen Healthcare Ltd) Has basis of strength substance Ranitidine true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Ranitidine 75mg tablets (Ennogen Healthcare Ltd) 12 tablet Has AMP True Ranitidine 75mg tablets (Ennogen Healthcare Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start